Companies/US/PLRX

PLIANT THERAPEUTICS, INC.

Last · NasdaqGS$0.8839-0.0841 (-8.69%)close · yahoo · 15h ago
Vol 988.9K ≈ 874.1K
Market cap$54.73M61.9M sh
P/E · TTM-0.7fwd -0.7 · eps -1.38 · loss
Beta1.28vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.8838$1.95
Volume988.9Ksession

Issuer

Legal namePLIANT THERAPEUTICS, INC.
HQUnited States (US)
ListingUS PLRX
ISINUS7291391057
LEI5493002Q5LITR7VHZH02
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001746473
CIK0001746473
Websitewww.pliantrx.com
Employees49
AddressPliant Therapeutics, Inc. 331 Oyster Point Boulevard 94080, South San Francisco +650 481 6770
Loading chart…

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.37
Est. revenue
0
View upcoming earnings →

Press & signals

3 recent
  • GlobeNewswire

    Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

  • GlobeNewswire

    Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

  • GlobeNewswire

    Pliant Therapeutics Names Flavia Borellini, Ph.D. and Robert Iannone, M.D., M.S.C.E. to Board of Directors

Documents

FormReporting forFiledFlags
4
2026-10-012026-10-020
10-Q
2026-06-302026-08-11 3
8-K8-K: Departure of Directors or Certain Officers; Election of Directors
2026-07-092026-07-130
Showing 3 of 3 filings